Techniques: Low-affinity chimeric antigen receptor (CAR) T cells to limit off-target effects of immunotherapy

Studies in mice suggest CAR T cells with low affinity for tumor-associated antigens could treat cancer with fewer off-target effects than high-affinity CAR T cells. In two studies, pairs of CAR T cell...